Medtecs International (Taiwan) Performance
| 9103 Stock | TWD 6.28 0.08 1.29% |
The company secures a Beta (Market Risk) of -0.014, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Medtecs International are expected to decrease at a much lower rate. During the bear market, Medtecs International is likely to outperform the market. At this point, Medtecs International has a negative expected return of -0.18%. Please make sure to verify Medtecs International's market risk adjusted performance, coefficient of variation, jensen alpha, as well as the relationship between the mean deviation and standard deviation , to decide if Medtecs International performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Medtecs International has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors. ...more
| Begin Period Cash Flow | 82.2 M | |
| Total Cashflows From Investing Activities | -15.4 M | |
| Free Cash Flow | 13.4 M |
Medtecs |
Medtecs International Relative Risk vs. Return Landscape
If you would invest 706.00 in Medtecs International on September 3, 2024 and sell it today you would lose (78.00) from holding Medtecs International or give up 11.05% of portfolio value over 90 days. Medtecs International is generating negative expected returns and assumes 1.1106% volatility on return distribution over the 90 days horizon. Simply put, 9% of stocks are less volatile than Medtecs, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Medtecs International Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medtecs International's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Medtecs International, and traders can use it to determine the average amount a Medtecs International's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1617
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 9103 |
Estimated Market Risk
| 1.11 actual daily | 9 91% of assets are more volatile |
Expected Return
| -0.18 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.16 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Medtecs International is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medtecs International by adding Medtecs International to a well-diversified portfolio.
Medtecs International Fundamentals Growth
Medtecs Stock prices reflect investors' perceptions of the future prospects and financial health of Medtecs International, and Medtecs International fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Medtecs Stock performance.
| Return On Equity | -0.0322 | |||
| Return On Asset | -0.0239 | |||
| Profit Margin | (0.06) % | |||
| Operating Margin | (0.09) % | |||
| Current Valuation | 1.58 B | |||
| Shares Outstanding | 544.91 M | |||
| Price To Earning | 515.00 X | |||
| Price To Book | 5.23 X | |||
| Price To Sales | 45.54 X | |||
| Revenue | 144.16 M | |||
| EBITDA | 24.4 M | |||
| Cash And Equivalents | 8.21 M | |||
| Cash Per Share | 0.01 X | |||
| Debt To Equity | 64.40 % | |||
| Book Value Per Share | 0.32 X | |||
| Cash Flow From Operations | 29.76 M | |||
| Earnings Per Share | 0.93 X | |||
| Total Asset | 215.57 M | |||
| Retained Earnings | 25 M | |||
| Current Asset | 64 M | |||
| Current Liabilities | 46 M | |||
About Medtecs International Performance
Evaluating Medtecs International's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Medtecs International has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Medtecs International has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Medtecs International Corporation Limited, an integrated healthcare products and services provider, manufactures and distributes medical consumables for healthcare distributors, pharmaceutical companies, and hospital groups worldwide. The company was founded in 1989 and is headquartered in Taipei City, Taiwan. MEDTECS INTERNATIONAL operates under Medical Devices classification in Taiwan and is traded on Taiwan Stock Exchange.Things to note about Medtecs International performance evaluation
Checking the ongoing alerts about Medtecs International for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Medtecs International help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Medtecs International generated a negative expected return over the last 90 days | |
| The company has NT$0.0 in debt which may indicate that it relies heavily on debt financing |
- Analyzing Medtecs International's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Medtecs International's stock is overvalued or undervalued compared to its peers.
- Examining Medtecs International's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Medtecs International's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Medtecs International's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Medtecs International's stock. These opinions can provide insight into Medtecs International's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Medtecs Stock Analysis
When running Medtecs International's price analysis, check to measure Medtecs International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtecs International is operating at the current time. Most of Medtecs International's value examination focuses on studying past and present price action to predict the probability of Medtecs International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtecs International's price. Additionally, you may evaluate how the addition of Medtecs International to your portfolios can decrease your overall portfolio volatility.